A Study to Evaluate Safety and Tolerability of Multiple Doses of MEDI-546 in Adult Subjects With Scleroderma

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
MedImmune LLC
ClinicalTrials.gov Identifier:
NCT00930683
First received: June 29, 2009
Last updated: May 7, 2012
Last verified: May 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2011
  Primary Completion Date: May 2010 (Final data collection date for primary outcome measure)
No publications provided by MedImmune LLC

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):